Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
98 pending office actions • 37 clients • 88 examiners • 55 art units • 0 of 98 (0%) have an AI response strategy ready
This profile covers Biotechnology & Pharmaceuticals and includes 5176 career applications. Its resolved allowance rate is 81.19%, with an average of 3.59 office actions per allowance. The record reflects a substantial prosecution base, an allowance outcome reported for a clear majority of resolved matters, and recurring examination activity before allowance.
There are 97 pending office actions, creating a significant active workload. That volume makes docket prioritization and consistent handling of recurring claim issues important for practitioners. The allowance rate and action average provide historical planning context, but they should not be treated as predictions for individual unresolved applications. Biotechnology and pharmaceutical cases may require tailored responses where the pending action presents distinct written-description, eligibility, or prior-art issues.
Based on the USPTO statutory response window for each pending office action. 28 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 28 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (1%) |
| §101 + other | 9 (9%) |
| §103 only | 26 (27%) |
| §102 only | 1 (1%) |
| §112 only | 7 (7%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 11 (11%) |
| Multi-statute (no §101) | 39 (40%) |
| No statute on record | 3 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORILLO, JANELL COMBS | 4 | 58.2% | +26.1% |
| REDDIG, PETER J | 2 | 58.0% | +40.2% |
| PRAKASH, SUBBALAKSHMI | 2 | 45.6% | +36.2% |
| NICKOL, GARY B | 2 | 46.6% | +33.3% |
| ZHENG, LOIS L | 2 | 67.6% | +13.0% |
| MORGAN, BAILEY MICHELLE | 2 | 56.3% | +58.3% |
| TURNER, FELICIA C | 2 | 26.2% | +30.2% |
| HAWKINS, AMANDA SALATA | 2 | 15.4% | +40.9% |
| MORENO, LARK JULIA | 1 | 0.0% | +0.0% |
| TENTONI, LEO B | 1 | 81.9% | +10.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17781682 | IMPROVED METHOD FOR MANUFACTURING A STRUCTURE COMPONENT FOR A MOTOR VEHICLE BODY | MORILLO, JANELL COMBS | 70d overdue |
| 15734727 | MODIFIED RAPESEED PROTEIN ISOLATE | TRAN, LIEN THUY | 45d overdue |
| 18156098 | THERMOMECHANICAL AGEING FOR 6XXX EXTRUSIONS | CARDA, DANIELLE MARIE | 26d overdue |
| 18548983 | FROZEN FOOD PRODUCT, NATURAL STABILIZER, FROZEN FOOD PRODUCTION METHOD AND THE SIEVE SYSTEM | BEKKER, KELLY JO | 9d overdue |
| 18002928 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | HEITMEIER, KENDALL NICOLE | 3d overdue |
| 18551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | COUNTS, GARY W | 5d |
| 17258670 | HEALTHCARE MANAGEMENT METHOD | HRANEK, KAREN AMANDA | 9d |
| 18347724 | PHENYL UNSATURATED KETONES AS HUMAN FACTOR XIIIA INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC DISEASES | DEKARSKE, MADELINE MCGUIRE | 13d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546604 | COATED MEAT OR FISH SUBSTITUTE | PRAKASH, SUBBALAKSHMI | 112d overdue |
| 17781682 | IMPROVED METHOD FOR MANUFACTURING A STRUCTURE COMPONENT FOR A MOTOR VEHICLE BODY | MORILLO, JANELL COMBS | 70d overdue |
| 17415590 | AL-ZN-CU-MG ALLOYS AND THEIR MANUFACTURING PROCESS | MORILLO, JANELL COMBS | 49d overdue |
| 18291819 | PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE | PRAKASH, SUBBALAKSHMI | 12d |
| 17906118 | USE OF PHYTASE TO OBTAIN IMPROVED FOOD | HAWKINS, AMANDA SALATA | 26d |
| 17842842 | PROCESS FOR PRODUCING OLIVE OIL | HAWKINS, AMANDA SALATA | 34d |
| 15734102 | USE OF PEPTIDYLARGININE DEIMINASE TO OBTAIN IMPROVED FOOD | TURNER, FELICIA C | 36d |
| 18451216 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | NICKOL, GARY B | 69d |
| Art Unit | Apps |
|---|---|
| 1793 | 9 |
| 1733 | 8 |
| 1643 | 4 |
| 1645 | 4 |
| 1623 | 3 |
| 1759 | 3 |
| 1621 | 3 |
| 1646 | 3 |
| 1758 | 2 |
| 1644 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19384727 | WINE DEHAZING METHODS AND COMPOSITIONS | Vinzymes, Inc. | MORENO, LARK JULIA | 1793 | §102§103 | Final Rejection | — | Pending | Nov 10, 2025 |
| 19114944 | POST-TREATMENT OF A 3D-PRINTED ELASTOMER SILICONE ARTICLE | Elkem Silicones Usa Corp. | TENTONI, LEO B | 1742 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 25, 2025 |
| 19110985 | DEVICE AND METHOD FOR CHECKING THE FLATNESS OF A METAL SHEET | Constellium Neuf-Brisach | DOUMBIA, MOHAMED | 2877 | §103§112 | Non-Final OA | — | Pending | Mar 12, 2025 |
| 19104827 | ORAL CARE COMPOSITIONS | Soluta Consult GmbH | HOLLOMAN, NANNETTE | 1612 | §103§112 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 18861903 | ARTICLE SUITABLE FOR FOOD CONTACT AND METHOD FOR PRODUCING SAME | Elkem Silicones France SAS | BEHA, CAROLINE | 1748 | §102§103§112 | Non-Final OA | — | Pending | Oct 31, 2024 |
| 18891013 | SULFONATED AND PHOSPHORYLATED AROMATIC MOLECULES | Xavier University Of Louisiana | BAUER, BRIANNA LEE | 1623 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18887856 | COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME | Aratana Therapeutics Inc. | MCMILLIAN, KARA RENITA | 1623 | §103Other | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18824203 | WPRE MUTANT CONSTRUCTS, COMPOSITIONS, AND METHODS THEREOF | Immatics US, Inc. | AMICK, THOMAS RUSSE | Other | Non-Final OA | — | Pending | Sep 04, 2024 | |
| 18809132 | STEVIOL GLYCOSIDE TRANSPORT | DSM IP ASSETS B.V. | LEE, JAE W | §102§112Other | Non-Final OA | — | Pending | Aug 19, 2024 | |
| 18793061 | GLYCATED PROTEIN SENSOR, MEASUREMENT METHOD, PROGRAM, AND SENSOR MANUFACTURE METHOD | Provigate Inc. | KAUR, GURPREET | 1759 | §102§103 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18730668 | MOLIDUSTAT FORMULATIONS AND METHODS OF USE FOR TREATMENT OF ANEMIA IN CATS | Elanco Animal Health GmbH | KIM, SEONG JONG | 1621 | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18725649 | METHOD, APPARATUS AND PIPETTE CARTRIDGE FOR MEASURING ELEMENT OF BLOOD CELL COMPONENT AND ELEMENT OF NON-BLOOD CELL COMPONENT IN MINUTE AMOUNT OF BLOOD | Provigate Inc. | FRITCHMAN, REBECCA M | 1758 | §103§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18753587 | DEVICE TO BE USED FOR CAPTURING EXTRACELLULAR VESICLES, AND PRESERVATION METHOD AND TRANSPORT METHOD FOR EXTRACELLULAR VESICLES | Craif Inc. | SHABMAN, MARK A | 2855 | §103 | Final Rejection | — | Pending | Jun 25, 2024 |
| 18714745 | 6XXX SERIES ALUMINIUM ALLOY SHEETS OR BLANKS WITH IMPROVED FORMABILITY | Constellium Neuf-Brisach | ALDAZ CERVANTES, MAYELA RENATA | 1733 | §102§103§112Other | Non-Final OA | — | Pending | May 30, 2024 |
| 18649164 | ALUMINUM-COPPER-LITHIUM ALLOY PRODUCTS | Constellium Issoire | LUK, VANESSA TIBAY | 1733 | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18647837 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | Immatics Biotechnologies GmbH | OUSPENSKI, ILIA I | 1644 | §112DP | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18642871 | NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME | Immatics Biotechnologies GmbH | REDDIG, PETER J | 1646 | Other | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18691184 | HIGH-MOISTURE TEXTURIZED VEGETABLE PROTEIN | DSM IP ASSETS B.V. | LIU, DEBORAH YANG-HAO | 1791 | §103 | Final Rejection | 8d overdue | Pending | Mar 12, 2024 |
| 18691213 | PLANT BASED READY TO MIX COMPOSITION | DSM IP ASSETS B.V. | LEBLANC, KATHERINE DEGUIRE | 1791 | §103 | Final Rejection | 46d | Pending | Mar 12, 2024 |
| 18690087 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH | SHTERENGARTS, SAMANTHA L | 1623 | §102DP | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18685689 | NEURAL-NETWORK-BASED CLASSIFIER | Craif Inc. | MESFIN, MATTHEWOS | 2145 | §102§103 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18291819 | PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE | DSM IP ASSETS B.V. | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Final Rejection | 12d | Pending | Jan 24, 2024 |
| 18580849 | PEA AND RAPESEED PROTEIN ISOLATE | DSM IP ASSETS B.V. | MCCLAIN, TYNESHA L. | 1793 | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18396656 | AUTOMATIC EXTRACTION DEVICE AND USE METHOD THEREFOR | Nanjing Genscript Biotech Co., Ltd. | WASHINGTON, BRITNEY NICOLE | 1797 | §103 | Final Rejection | — | Pending | Dec 26, 2023 |
| 18573017 | HYALURONIC ACID DERMAL FILLERS CROSSLINKED WITH POLYETHYLENE GLYCOL DIGLYCIDYL ETHER, METHOD FOR MAKING SAME AND USES THEREOF | Merz Pharama GmbH & Co. Kgaa | AL-AWADI, DANAH J | 1615 | §103§112 | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18533733 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | SANG, HONG | 1646 | §102§103§112DP | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18567588 | ALUMINUM ALLOY PLATE SHEET FOR PARALLELEPIPED BATTERY HOUSING | Constellium Rolled Products Singen GmbH & Co.Kg | ROE, JESSEE RANDALL | 1759 | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18529656 | AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY NON-HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | Immatics Biotechnologies GmbH | ESSEX, LAURA ANN | 1649 | §112Other | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18566522 | ANTIBODY SPECIFIC FOR ANTI-BCL-6 ANTIBODY AND METHODS OF USE | Nonagen Therapeutics Corporation | WANG, CHANG YU | 1675 | §112 | Final Rejection | — | Pending | Dec 01, 2023 |
| 18565741 | SEMICONDUCTOR SUBSTRATE ASSEMBLY AND MANUFACTURING METHOD THEREFOR | BONDTECH CO., LTD. | RIRIE, EVERETT TRAJAN | 2897 | §103 | Final Rejection | — | Pending | Nov 30, 2023 |
| 18564921 | RECOMBINANT PROTEINACEOUS BINDING MOLECULES | Julius-Maximilians-Universitaet Wuerzburg | NICKOL, GARY B | 1643 | §101§102§112 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18563134 | FED-BATCH FERMENTATION PROCESS | DSM IP ASSETS B.V. | HURST, JONATHAN M | 1799 | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18561758 | A 6XXX ALLOY FOR HIGH STRENGTH EXTRUDED PRODUCTS WITH HIGH PROCESSABILITY | CONSTELLIUM EXTRUSIONS LEVICE S.R.O. | MORILLO, JANELL COMBS | 1733 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18505361 | METHODS OF IDENTIFYING METASTATIC LESIONS IN A PATIENT AND TREATING THEREOF | Immatics Biotechnologies GmbH | REDDIG, PETER J | 1646 | §103DP | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18560035 | COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES | The United States Department of Health and Human Services | WHITEMAN, BRIAN A | 1636 | §101§103§112 | Final Rejection | — | Pending | Nov 09, 2023 |
| 18558222 | STRIP OR SHEET OF ALUMINIUM ALLOY FOR MANUFACTURING BRAZED HEAT EXCHANGERS | Constellium Neuf-Brisach | ZHENG, LOIS L | 1733 | §103Other | Final Rejection | — | Pending | Oct 31, 2023 |
| 18498631 | ANTI-GUCY2C ANTIBODY AND USES THEREOF | Heidelberg Pharma Research GmbH | DONOGHUE, BRITTNEY ERIN | 1675 | §112DP | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18558040 | 5XXX ALUMINIUM SHEETS FOR CAN MAKING | Constellium Rolled Products Singen GmbH & Co. Kg | CHRISTY, KATHERINE A | 1784 | §103 | Final Rejection | 4d overdue | Pending | Oct 30, 2023 |
| 18556008 | 5XXX ALUMINIUM SHEETS WITH HIGH FORMABILTY | Constellium Neuf-Brisach | KESSLER, CHRISTOPHER S | 1759 | §102§103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18484980 | STREPTOCOCCUS THERMOPHILUS STARTER STRAIN | DSM IP ASSETS B.V. | ZEMAN, ROBERT A | 1645 | §101§102§112 | Final Rejection | — | Pending | Oct 11, 2023 |
| 18551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | Celltrend GmbH | COUNTS, GARY W | 1678 | §101 | Final Rejection | 5d | Pending | Sep 20, 2023 |
| 18548983 | FROZEN FOOD PRODUCT, NATURAL STABILIZER, FROZEN FOOD PRODUCTION METHOD AND THE SIEVE SYSTEM | Krzysztof Ciuhak | BEKKER, KELLY JO | 1792 | §102§103§112 | Final Rejection | 9d overdue | Pending | Sep 05, 2023 |
| 18451216 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | NICKOL, GARY B | 1643 | §112Other | Final Rejection | 69d | Pending | Aug 17, 2023 |
| 18546604 | COATED MEAT OR FISH SUBSTITUTE | DSM IP ASSETS B.V. | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Non-Final OA | 112d overdue | Pending | Aug 16, 2023 |
| 18448998 | THICK PLATES MADE OF AL-CU-LI ALLOY WITH IMPROVED FATIGUE PROPERTIES | Constellium Issoire | WALCK, BRIAN D | 1738 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18366306 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES | Elanco Animal Health GmbH | RAHMAN, MASUDUR | 1633 | §103§112 | Non-Final OA | 34d | Pending | Aug 07, 2023 |
| 18262975 | VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE | Elanco Animal Health GmbH | MORGAN, BAILEY MICHELLE | 1645 | §103§112DP | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18262949 | VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE | Elanco Animal Health GmbH | MORGAN, BAILEY MICHELLE | 1645 | §103§112DP | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18262043 | METHOD AND APPARATUS FOR EVALUATING DEGREE OF GLYCATION OF PROTEIN | Provigate Inc. | HUANG, MICKEY NMN | 1758 | §103 | Final Rejection | 19d overdue | Pending | Jul 19, 2023 |
| 18262125 | MICROPLATE, MEASUREMENT METHOD USING THE SAME, AUTOMATIC MEASUREMENT SYSTEM, AND PROGRAM | Provigate Inc. | HERON, VELVET ELIZABETH | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.2% of resolved applications prosecuted by Mcbee Moore & Vanik, Ip, LLC were allowed, across 5,176 applications in USPTO records.
3.59 office actions per allowed application on average.
98 pending office actions as of October 2026, for 37 clients, before 88 examiners in 55 art units.
